MedTrace Logo

Comparison of Synchronous and Asynchronous Action Observation Therapy in Children With Cerebral Palsy

NCT07114731 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2026-03-06

No results posted yet for this study

Summary

The aim of this study is to compare the effects of synchronous and asynchronous action observation therapy (AOT) on balance, gait, and functional capacity in children with cerebral palsy (CP). CP is a neurodevelopmental disorder characterized by impairments in motor skills, particularly motor control and postural balance. By examining the contributions of synchronous (real-time) and asynchronous (delayed) AOT methods to motor performance, this study seeks to identify the most effective therapeutic approach for this population.

Conditions

  • Cerebral Palsy (CP)
  • Spastic Diplegia Cerebral Palsy
  • Spastic Hemiplegic Cerebral Palsy
  • Neurodevelopmental Disorder (Diagnosis)
  • Action Observation
  • Action Observation Therapy

Interventions

OTHER

Synchronous Action Observation Therapy

Real-time observation and execution of motor tasks through structured video modules designed based on participants' GMFCS level and extremity involvement.

OTHER

Asynchronous Action Observation Therapy

Observation of structured motor task videos followed by delayed execution, adapted to individual GMFCS levels and extremity involvement patterns.

Sponsors & Collaborators

  • Istanbul University - Cerrahpasa

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-04
Primary Completion
2025-10-06
Completion
2025-10-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07114731 on ClinicalTrials.gov